Have any questions?
+44 1234 567 890
EU, European Union - European Regional Development Fund (ERDF)
GeneQuine‘s project for the development of a gene therapy for intervertebral disc degeneration (GQ-401) is supported by a grant from the German state of Brandenburg (ProFIT Brandeburg), co-financed by the European Regional Development Fund (ERDF) by the European Union.
The aim of this project is to develop a gene therapy approach for treatment of intervertebral disc degeneration and to evaluate a product candidate preclinically.